Cellular Therapies in Hematologic Malignancies: Trends & Market Access Implications Across Care Settings January 29, 2026
Delivering Real World Evidence That Matters to Payers: Insights from a Survey of Access Decision Makers January 14, 2026
FDA’s Plausible Mechanism Pathway: A Regulatory Shift with Significant Market Access Implications December 17, 2025